Starling Oncology (STLN) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 4 34 sessions, August 4, 2026 to September 21, 2026
- Largest daily move
- +28.5% close of August 7, 2026
Company Description
Starling Oncology (NASDAQ: STLN) is classified in the medical care facilities industry within the Healthcare sector and carries a market capitalization of $696.1M.
STLN has gained 5.6% over the past month. The last closing price was $6.83.
For FY2025, Starling Oncology reported revenue of $502.7M and diluted earnings per share of -$0.54.
This page collects what Stock Titan holds for STLN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Starling Oncology (STLN) closed at $6.83 on September 21, 2026. Over the past month, the price has gained 5.6%.
STLN Metrics & Rankings
Price returns through September 21, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Starling Oncology has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include earnings. View all STLN news →
SEC Filings
Starling Oncology has filed 4 recent SEC filings, including 2 Form 8-K, 1 Form 4, 1 Form 144. The most recent filing was submitted on September 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all STLN SEC filings →
Insider Radar
Insider selling at Starling Oncology over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Starling Oncology generated $502.7M in revenue in FY2025, and operating income reached -$36.1M (-7.2% operating margin). Diluted earnings per share stood at -$0.54. The company generated -$24.6M in operating cash flow. With a current ratio of 1.59, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Starling Oncology (STLN) currently stands at 6.8 million shares, down 1.0% from the previous reporting period, representing 8.1% of the float. The 5.6 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Starling Oncology (STLN) currently stands at 5.6 days, up 59% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 59% over the past year, indicating either rising short interest or declining trading volume.
STLN Company Profile & Sector Positioning
Starling Oncology (STLN) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the NASDAQ.